Breaking News
The 3 Reasons Behind US Plot to Depose Venezuela's Maduro – Video #254
Evangelicals and the Veneration of Israel
Zohran Mamdani's Socialist Recipe for Economic Destruction
BREAKING: Fed-Up Citizens Sue New York AG Letitia James for Voter Intimidation...
Top Tech News
HUGE 32kWh LiFePO4 DIY Battery w/ 628Ah Cells! 90 Minute Build
What Has Bitcoin Become 17 Years After Satoshi Nakamoto Published The Whitepaper?
Japan just injected artificial blood into a human. No blood type needed. No refrigeration.
The 6 Best LLM Tools To Run Models Locally
Testing My First Sodium-Ion Solar Battery
A man once paralyzed from the waist down now stands on his own, not with machines or wires,...
Review: Thumb-sized thermal camera turns your phone into a smart tool
Army To Bring Nuclear Microreactors To Its Bases By 2028
Nissan Says It's On Track For Solid-State Batteries That Double EV Range By 2028
Carbon based computers that run on iron
'TUMOUR KILLER' Cancer patients 'CURED' after doctors turbocharge their blood's
Two adults with leukaemia have been in remission since 2010 after Car-T therapy.
It involves removing blood and genetically modifying its white cells so they target cancer.
The resulting Car-T cells are re-injected in a type of immunotherapy which uses the body's immune system to attack tumours.
Levels of the cells in the two cured patients remain high.
Dr Carl June, of the University of Pennsylvania, US, said: "Based on these results, we can conclude that Car-T cells can cure leukaemia.
"These cells continued to demonstrate tumour-killing characteristics."
Patient Doug Olsen said medics could not find any cancer after a few weeks. He said: "I knew the doctors weren't sure but I was pretty convinced that I was done with cancer."
The NHS offers Car-T to some children with leukaemia and adults with lymphoma.
It warns the therapy can make the immune system over-react or trigger side effects such as fever, vomiting or breathing difficulties.